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Abstract
Background: Although structural magnetic resonance imaging (MRI) studies have repeatedly demonstrated regional brain
structural abnormalities in patients with schizophrenia, relatively few MRI-based studies have attempted to distinguish
between patients with first-episode schizophrenia and healthy controls.
Method: Three-dimensional MR images were acquired from 52 (29 males, 23 females) first-episode schizophrenia patients
and 40 (22 males, 18 females) healthy subjects. Multiple brain measures (regional brain volume and cortical thickness) were
calculated by a fully automated procedure and were used for group comparison and classification by linear discriminant
function analysis.
Results: Schizophrenia patients showed gray matter volume reductions and cortical thinning in various brain regions
predominantly in prefrontal and temporal cortices compared with controls. The classifiers obtained from 66 subjects of the
first group successfully assigned 26 subjects of the second group with accuracy above 80%.
Conclusion: Our results showed that combinations of automated brain measures successfully differentiated first-episode
schizophrenia patients from healthy controls. Such neuroimaging approaches may provide objective biological information
adjunct to clinical diagnosis of early schizophrenia.
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Introduction
Schizophrenia is a disabling psychiatric disorder which usually
begins to affect individuals during their adolescence or early
adulthood and most patients continue to suffer social, economic,
and psychological difficulties from the first manifestation of the
illness. Currently, diagnoses of psychiatric disorders are made on
the basis of clinical manifestations and associated psycho-social
disturbances [1,2]. However, there is an evidence for diagnostic
instability in psychotic patients at an early stage of illness [3,4].
Although an accurate diagnosis is considered a prerequisite for
appropriate physical/psychological treatment for each patient, no
objective biomarker has been identified.
Previous structural magnetic resonance imaging (MRI) studies
have demonstrated gray matter reductions of fronto-temporolimbic
brain regions in schizophrenia patients compared with those of
healthy subjects [5–11]. Several MRI-based studies have attempted
to distinguish schizophrenia patients from healthy subjects using a
variety of approaches such as manually traced regions of interest
(ROI) [12,13], voxel-based morphometry (VBM) [14–16], cortical
pattern matching [17], and cortical thickness obtained by a surface-
based approach [18]. These studies have generally reported high
classification accuracies (ranging from 75% to 92%), suggesting the
potential clinical (i.e., diagnostic) utility of structural MRI. The
majority of such classification studies employed chronic schizophre-
nia patients [12,14–16,18]. To date, only two studies [13,17] have
attempted to distinguish between first-episode patients and healthy
subjects by structural MRI.
Recently, an automated surface-based approach which can
reliably measure local mean cortical thickness has been developed
[19]. Several MRI studies applying this technique to schizophrenia
have yielded robust findings such as cortical thinning especially in
prefrontal and temporal regions [20–25]. This surface-based
approach also enables to perform cortical parcellation and
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e21047Figure 1. Representations of ROIs examined in this study on the left hemisphere. Cortical ROIs are shown in lateral view (left) and medial
view (right). Two subcortical ROIs (i.e., amygdala and hippocampus) are visible in coronal view (middle).
doi:10.1371/journal.pone.0021047.g001
Table 1. Demographic and clinical characteristics of the male subjects.
A. First group Control subjects Schizophrenia patients Analysis of variance
n=16 n=20
Mean SD Mean SD F p
Age (years) 29.9 5.6 27.8 6.0 1.19 0.28
Handedness (number of right-handed) 16.0 19.0
Socio-economic status 1.6 0.5 2.7 1.0 13.07 0.001
Parental socio-economic status 2.3 0.6 2.4 0.8 0.23 0.63
Estimated IQ 108.8 7.9 103.0 9.7 3.68 0.06
Duration of illness (months) 9.9 11.1
Total BPRS score 40.2 11.5
Antipsychotic medication (mg/day, chlorpromazine equiv.) 1074.5 487.9
B. Second group Control subjects Schizophrenia patients Analysis of variance
n=6 n=9
Mean SD Mean SD F p
Age (years) 30.8 6.0 27.9 6.8 0.74 0.41
Handedness (number of right-handed) 6.0 7.0
Socio-economic status 1.8 0.5 3.9 1.6 9.68 0.01
Parental socio-economic status 2.3 0.4 2.3 0.7 0.37 0.56
Estimated IQ 111.7 5.1 106.2 10.6 1.38 0.26
Duration of illness (months) 12.5 13.0
Total BPRS score 42.5 9.9
Antipsychotic medication (mg/day, chlorpromazine equiv.) 864.4 637.7
doi:10.1371/journal.pone.0021047.t001
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approaches have been validated by several studies [21,26,28,29].
By using these newly developed automated methods to assess brain
morphology (i.e., cortical thickness and regional brain volumes).
Desikan et al. [30] demonstrated successful classification of
subjects with mild cognitive impairment, patients with Alzheimer’s
disease, and controls. To our knowledge, however, no studies have
attempted to classify patients with schizophrenia and healthy
subjects with this fully automated MRI-based analysis.
In this study, we intended to classify schizophrenia patients and
healthy subjects using discriminant analysis with automated MRI-
based measures of regional brain volume and cortical thickness.
On the basis of findings of previous studies, we hypothesized that
(1) cortical thinning and gray matter volume reductions in
prefrontal and temporal regions would be seen in schizophrenia
patients compared with controls, (2) and these MRI measures




Fifty-two patients (29 males, 23 females) with first-episode
schizophrenia were recruited from the inpatient population at
Tokyo Metropolitan Matsuzawa Hospital. Inclusion criteria for
first-episode schizophrenia patients were (1) first psychiatric
hospitalization, (2) younger than 45 years old, (3) currently
psychotic as reflected by the presence of at least one ‘‘positive’’
symptom, and (4) fulfilling the ICD-10 research criteria for
schizophrenia. Two experienced psychiatrists separately examined
the patients within two weeks of admission and diagnostic
consensus was confirmed. Furthermore, thorough medical record
review was performed to confirm the diagnostic stability for all the
patients during the follow-up periods (1 to 5 years) after first
admission. All but three male patients with schizophrenia were
right-handed. All patients had received antipsychotic medications
at the time of scanning.
The control subjects consisted of 40 healthy volunteers (22
males, 18 females) who were recruited from the hospital staff and
college students. All of the control subjects were right-handed. All
control subjects were interviewed by psychiatrists using the
questionnaire concerning their family and past histories, and
present illness. Individuals who had a personal history of
psychiatric illness or a family history of psychiatric disorders in
their first degree relatives were excluded.
For the discriminant analysis described below, the subjects were
randomly assigned to two independent groups. The first group
consisted of 36 males (16 healthy subjects and 20 schizophrenia
patients) and 30 females (13 healthy subjects and 17 schizophrenia
patients). The second group for the prospective validation
consisted of 15 males (6 healthy subjects and 9 schizophrenia
patients) and 11 females (5 healthy subjects and 6 schizophrenia
patients). Since the sample size of the present study is relatively
modest, we assigned more subjects to the first group (i.e., about
70%) than to the second group to enhance the discriminating
ability of the classifier.
In the schizophrenia patients, clinical symptoms were assessed
using the Brief Psychiatric Rating Scale (BPRS) [31]. The
premorbid IQ for schizophrenia patients and the present IQ for
control subjects were estimated using the shortened version of the
Table 2. Demographic and clinical characteristics of the female subjects.
A. First group Control subjects Schizophrenia patients Analysis of variance
n=13 n=17
Mean SD Mean SD F p
Age (years) 27.5 4.8 28.1 5.8 0.16 0.69
Handedness (number of right-handed) 14.0 17.0
Socio-economic status 1.6 0.5 3.1 1.1 17.14 ,0.001
Parental socio-economic status 2.4 0.8 2.9 0.8 3.03 0.09
Estimated IQ 107.0 8.1 103.5 7.8 2.55 0.12
Duration of illness (months) 13.0 12.6
Total BPRS score 37.4 9.7
Antipsychotic medication (mg/day, chlorpromazine equiv.) 930.8 451.6
B. Second group Control subjects Schizophrenia patients Analysis of variance
n=5 n=6
Mean SD Mean SD F p
Age (years) 28.4 3.8 28.3 8.6 0.05 0.83
Handedness (number of right-handed) 4.0 6.0
Socio-economic status 1.6 0.5 2.5 1.0 4.65 0.06
Parental socio-economic status 2.0 0.0 2.6 0.9 2.25 0.17
Estimated IQ 108.1 10.8 103.0 8.1 0.18 0.68
Duration of illness (months) 14.5 19.8
Total BPRS score 36.5 4.4
Antipsychotic medication (mg/day, chlorpromazine equiv.) 483.3 263.9
doi:10.1371/journal.pone.0021047.t002
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The subjects’ socio-economic status (SES) as well as parental SES
was assessed using the Hollingshead’s Index [33].
All subjects were physically healthy at the time of the study,
and none had a lifetime history of serious head trauma,
neurological illness, or serious medical or surgical illness.
Individuals who met the ICD-10 research criteria for mental
and behavioral disorders due to psychoactive substance use were
excluded. All schizophrenia patients participated in this study
after providing written informed consent. In addition, regal
representatives of schizophrenia patients gave written informed
consent. In case of unable to directly access to a patient’s legal
representative, oral informed consent was obtained using
telephone, and this procedure was witnessed by at least two
hospital staff and recorded in the medical chart. All control
subjects also provided written informed consent. Since control
group of this study consisted of only healthy adults, their legal
representatives were not asked to give informed consents. This
study was approved by the Committee on Medical Ethics of
Tokyo Metropolitan Matsuzawa Hospital.
MRI data acquisition
MR images were obtained using a Philips Intera 1.5-T scanner
(Philips Medical Systems, Best, Netherlands) with a three-
dimensional sequence yielding 192 contiguous T1-weighted slices
of 1.0-mm thickness in the axial plane. The imaging parameters
were as follows: repetition time=21 ms, echo time=9.2 ms, flip
angle=30u, field of view=256 mm, matrix size=2566256 pixels,
voxel size=1.061.061.0 mm
3.
Automated MRI data processing
Cortical reconstruction and volumetric segmentation were
performed with the Freesurfer image analysis suite (version 4.5),
which is documented and freely available for download online
(http://surfer.nmr.mgh.harvard.edu/). This processing includes
motion correction and averaging of multiple volumetric T1-
weighted images, removal of non-brain tissue using a hybrid
watershed/surface deformation procedure [34], automated Talair-
ach transformation, segmentation of the subcortical white matter
and deep gray matter volumetric structures (including hippocampus
and amygdala) [35,36], intensity normalization [37], tessellation of
the gray matter/white matter boundary, automated topology
correction [38,39], and surface deformation following intensity
gradients to optimally place the gray/white and gray/cerebrospinal
fluid(CSF)bordersatthelocation wherethegreatestshift in intensity
defines the transition to the other tissue class [19,40,41]. Once the
cortical models are completed, a number of deformable procedures
can be performed for further data processing and analysis.
Cortical thickness measurements were obtained by calculating
the shortest distance from the gray/white boundary to the gray/
CSF boundary at each vertex on the tessellated surface [19]. The
cerebral cortex of each MRI scan was automatically parcelled into
regions of interest (ROIs) based on gyral and sulcal structure
[26,42]. Both automated cortical thickness measurements and
cortical parcellation have already been validated [21,26,28,29].
Figure 1 presents the neocortical ROIs and two limbic ROIs
(hippocampus and amygdala) examined in this study. To control
for head size in statistical analyses, the total intracranial volume
(ICV) was calculated automatically [43].
Figure 2. ROIs for which the volumes were significantly reduced in schizophrenia patients compared with those of healthy subjects.
ROIs were differentially colored according to the p values of the post hoc tests.
doi:10.1371/journal.pone.0021047.g002
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Demographic and clinical variables were compared by analysis
of variance (ANOVA). The ROI volumes and the mean cortical
thickness of ROIs were analyzed by repeated measures analysis of
covariance (ANCOVA) with diagnosis and gender as between-
subject factors, hemisphere (left, right) as a within-subject factor,
and age and ICV as covariates. To prevent possible type 1 error,
we used false positive discovery rate (FDR) correction. For
variables of which p-values remained significant even after the
FDR correction, post hoc Scheffe’s tests were used to follow up
significant main effects or interactions.
Statistical analysis-2 Classification by brain measures
The following statistical procedures were carried out separately
for each gender, as was the case in our previous studies [12,13], on
the basis of the gender differences in brain morphology found in
this study (described below) as well as the evidence for gender
differences in brain morphology among healthy subjects [44] and
gender-specific brain structural changes in schizophrenia patients
[45,46].
Transformation of brain measures into z scores. The
volumes and mean cortical thickness of ROIs were expressed as
standardized z scores corrected by regression analysis for the
variations in head size and age of the control subjects, as described
in our previous studies [12,13]. Briefly, the ROI volume and mean
cortical thickness for the control group were regressed against ICV
and age, yielding a residual value for each control subject. The
ROI volume and mean cortical thickness for the patient groups
were entered into the same equation as for the control group to
calculate the residual value for each patient. The mean residual
values and standard deviation (SD) derived from the control
subjects were used to calculate z scores (z=[residual value - mean
residual value for control subjects]/SD). For the control subjects,
the expected mean z score was 0 with an SD of 1. The use of
standardized z scores allows analysis of disease-related changes
independent of head size and normal aging.
Linear discriminant function analysis. For the first group,
discriminant function analysis was conducted using z scores as
independent variables to assess the possibility of classifying
diagnostic groups by a combination of brain measures. The
variables were entered in a stepwise manner. Since we employed a
stepwise variable selection, the number of variables which were
entered into the discriminant analysis varied depending on the
inclusion and exclusion criteria. In this study, relatively
conservative inclusion criteria were used for the stepwise
selection, which were set at p,0.05 to enter and p.0.1 to
remove. If we used a more liberal criterion, more variables could
be used for the discriminant function, vice versa. For each step,
always a measure whose p-value is the smallest and smaller than
0.05 is entered to the discriminant function. Similar to a stepwise
linear regression analysis, however, p-values of variables vary for
each step. If a p-value of a measure that has already been entered
to the model exceeds 0.1, this variable is removed at this step. If a
p-value of the measure is 0.06 (i.e., ,0.1), it remains in the model.
However, if a measure with a p-value of 0.06 has yet to be entered
in the model, it is still out of the model at this step. For each
subject of the second group, the discriminant score was calculated
using the discriminant function derived from the first group and
his/her diagnosis was predicted based on the discriminant score.
Since the p-value for the stepwise variable selection was computed
Figure 3. Significant cortical thinning of ROIs in schizophrenia patients compared with that of healthy subjects observed in this
study. ROIs were differentially colored according to the p values of the post hoc tests.
doi:10.1371/journal.pone.0021047.g003
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was achieved independently of subjects’ diagnosis of the second
group. Sensitivity, specificity, accuracy, positive predictive value
(PPV), negative predictive value (NPV), and false positive rate
(FPR) of the classifier were calculated. Detailed descriptions of
discriminant function analysis and stepwise variable selection can
be found at the Statsoft website (http://www.statsoft.com/
textbook/).
All statistical analyses were performed using the STATISTICA
06J software package (Statsoft, Tulsa, OK).
Results
Demographic and clinical characteristics
Tables 1 and 2 present the results of group comparison of the
demographic and clinical measures of male subjects and female
subjects, respectively. When all subjects were combined, there
were significant main effects of diagnosis on SES (F=41.77,
df=1,87, p,0.001) and estimated IQ (F=6.90, df=1,85,
p=0.01). Post hoc tests showed that schizophrenia patients had
lower SES (p,0.001) and lower estimated IQ (p=0.01) than
controls.
Comparison of the brain measures
Tables S1 and S2 show the comparisons of the volumes and the
mean cortical thicknesses of ROIs among diagnostic groups,
respectively. Below, we describe the significant results of post hoc
tests.
Comparison of the ROI volumes. Post hoc tests
demonstrated significant gray matter volume reductions of the
bilateral hippocampus (p,0.001 for both hemispheres), the
bilateral fusiform gyri (p=0.002 for left, p=0.024 for right), and
the bilateral lateral occipital cortices (p=0.001 for left, p=0.014
for right) in schizophrenia patients compared with those of healthy
subjects (Figure 2). Gender differences of ROI volumes were seen
in the bilateral amygdala (male.female, p,0.001 for both
hemispheres).
Comparison of the mean thickness of ROIs. Significant
cortical thinning in schizophrenia patients compared with controls
was observed in the bilateral rostral middle frontal gyri (p=0.007
for left, p=0.007 for right), the bilateral pars opecularis (p=0.002
for left, p,0.001 for right), the bilateral pars triangularis (p,0.001
for left, p=0.009 for right), the bilateral pars orbitalis (p=0.002
for left, p,0.001 for right), the bilateral lateral orbitofrontal
cortices (p,0.001 for both hemispheres), the bilateral superior
temporal gyri (p,0.001 for left, p=0.001 for right), the bilateral
middle temporal gyri (p,0.001 for both hemispheres), the bilateral
inferior temporal gyri (p,0.001 for both hemispheres), the
bilateral fusiform gyri (p=0.005 for left, p,0.001 for right), and
the bilateral temporal pole (p=0.004 for left, p=0.04 for right)
(Figure 3).
Classification of schizophrenia patients and healthy
subjects by brain measures
Among male subjects, the following 2 measures were entered in
a stepwise manner: the left lateral occipital cortex volume and
right lateral orbitofrontal cortex thickness (Figure 4). Accuracy,
sensitivity, specificity, PPV, NPV and FPV of the obtained
classifier were 86.1%, 80.0%, 93.8%, 94.1%, 78.9%, and 5.9%,
respectively in the first male cohort. In the second cohort, the
Figure 4. Discriminative pattern for male subjects. Selected regions were differentially colored when volume (blue) or thickness (yellow) of
those regions were entered into the model.
doi:10.1371/journal.pone.0021047.g004
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sensitivity, specificity, PPV, NPV and FPV for second cohort were
86.7%, 88.9%, 83.3%, 88.9%, 83.3%, and 11.1%, respectively
(Table 3).
During the stepwise procedure, the following 5 measures were
selected as variables in female subjects: the left temporal pole
volume, the right medial orbitofrontal cortex volume, the right
pars triangularis volume, the left pars orbitalis thickness, and the
left superior temporal gyrus thickness (Figure 5). Accuracy,
sensitivity, specificity, PPV, NPV and FPV of the classifier were
96.7%, 94.1%, 100%, 100%, 92.9%, and 0%, respectively in the
first female cohort. Obtained classifier correctly classified 81.2% of
the subjects of the second cohort. Accuracy, sensitivity, specificity,
PPV, NPV and FPV for the second cohort were 81.2%, 66.7%,
100%, 100%, 71.4%, and 0%, respectively (Table 3).
Discussion
Classification performance
To the best of our knowledge, this is the first MRI study to
reliably classify first-episode patients with schizophrenia and
healthy subjects using fully automated MRI-based discriminant
analysis based on both brain regional volumes and regional
cortical thicknesses. Our results were comparable to those of
previous MRI-based classification studies in chronic [14–16,18]
and first-episode [13,17] schizophrenia patients. Our results
suggest that the combination of automated brain measures is a
candidate for an objective biological marker of early schizophrenia
adjunct to clinical diagnosis.
In the present study, the fronto-temporolimbic regions as well as
the occipital cortex exhibited the discriminative patterns among
the diagnostic groups. These patterns appear to be somewhat
different from those of previous classification studies between
schizophrenia patients and healthy controls using whole brain
analysis by VBM [16] or cortical pattern matching [17], which
highlighted the fronto-temporal regions as contributing to
between-group differentiation. Interestingly, we replicated recent
findings by Rimol et al. [47] in showing robust cortical thinning of
posterior cortices in first-episode schizophrenia. Our results might
thus suggest that combination of cortical thickness (including
occipital regions) and gray matter volume contributed to high
classification accuracies reported in this study.
Several studies have attempted to distinguish between persons
with psychiatric conditions and healthy controls using neuropsy-
chological tests [48], a combination of structural brain measures
and neuropsychological tests [49], and functional MRI [50].
Although these previous studies also reported high classification
accuracy, neuropsychological and functional measures are con-
sidered more susceptible to the subjects’ condition (i.e., state-
dependent). In contrast, brain morphologic changes in schizo-
phrenia are considered to be more static and already exist at the
first episode of the illness [5] or even before/during the onset of
overt psychosis [51–53] Our findings that MRI measures alone
could reliably differentiate healthy controls and schizophrenia
patients might thus suggest a role of brain structural measures in
the earlier detection of psychosis. In fact, a recent VBM-based
classification study demonstrated successful discrimination of
individuals with at risk mental state (ARMS) who later developed
psychosis from those without transition to psychosis [54].
Volume reductions and cortical thinning of ROIs in
patients
This study demonstrated significant gray matter volume
reductions of temporal, limbic, and occipital regions in schizo-
phrenia patients compared with those of controls. In schizophrenia
patients, significant cortical thinning was more widely observed,
relative to volume reductions, in prefrontal and temporal regions.
These results are consistent with previous studies that reported
fronto-temporolimbic gray matter volume reductions [5–11] and
cortical thinning of prefrontal/temporal regions [20–25] in
schizophrenia patients. Prefrontal and temporolimbic regions are
considered to be involved in cognitive function, auditory/visual
processing, speech, emotional processing, executive function, and
decision-making, all of which are often impaired in schizophrenia
patients [55–57]. Onitsuka et al. [58] demonstrated volume
reductions of the bilateral occipital sub-region (the visual
association areas), which largely includes the lateral occipital
cortex where the schizophrenia patients had a decreased volume
in this study. In general, the present study has replicated the brain
structural abnormalities in schizophrenia patients demonstrated in
previous MRI-based studies.
Gender difference was seen in the bilateral amygdala volume
(male.female) in accordance with previous studies [44]. In order
to exclude such gender effect which potentially confounds
classification analyses, we divided the subjects into male and
female cohorts in this study.
Limitations
A few limitations in this study should be taken into account.
First, this study was partly limited by the lack of inclusion of other
Table 3. Classification performance.
A. First group Male (n=36) Female (n=30)
Predicted diagnosis Predicted diagnosis
HC SZ HC SZ
Clinical diagnosis
HC 15 1 13 0
SZ 4 16 1 16
Accuracy (%) 86.1 96.7
Sensitivity (%) 80.0 94.1
Specificity (%) 93.8 100.0
PPV (%) 94.1 100.0
NPV (%) 78.9 92.9
FPR (%) 5.9 0.0
B. Second group Male (n=15) Female (n=11)
Predicted diagnosis Predicted diagnosis
HC SZ HC SZ
Clinical diagnosis
H C 51 50
S Z 18 24
Accuracy (%) 86.7 81.2
Sensitivity (%) 88.9 66.7
Specificity (%) 83.3 100.0
PPV (%) 88.9 100.0
NPV (%) 83.3 71.4
FPR (%) 11.1 0.0
FPR, false positive rate; HC, healthy control; NPV, negative predictive value; PPV,
Positive predictive value; SZ, schizophrenia.
doi:10.1371/journal.pone.0021047.t003
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preliminary classification analysis using the current sample as well
as 15 BD patients [8 males (mean age, 33.5 years) and 7 females
(mean age, 33.7 years)] correctly assigned 81.4% of male subjects
and 87.5% of female subjects, respectively (unpublished data).
However, larger number of BD patients will be needed to
delineate the conclusion that such technique may possibly attribute
to the clinical diagnosis of different psychiatric conditions. Second,
the higher socio-economic status of control group compared to
schizophrenia patients might have confounded the analyses,
although parental socio-economic status was not different between
groups. Third, the results may have been influenced by
antipsychotic medication that all patients in this study had
received prior to scanning [59–61]. Finally, as the sample size of
this study is modest (51 males and 41 females), we needed to assign
more subjects to the training cohort than to the validation cohort
in order to obtain more reliable classifiers. A larger number of
subjects should be tested for validation in future study.
Conclusion
In conclusion, our results showed that combinations of fully
automated brain measures successfully classified diagnostic groups
(i.e., schizophrenia patients and controls), and suggest that such
neuroimaging approaches may provide objective biological
information adjunct to clinical diagnosis of early schizophrenia.
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